Literature DB >> 3486416

Characterization, mapping, and expression of the human ceruloplasmin gene.

F Yang, S L Naylor, J B Lum, S Cutshaw, J L McCombs, K H Naberhaus, J R McGill, G S Adrian, C M Moore, D R Barnett.   

Abstract

Ceruloplasmin (CP) is a copper-binding protein in vertebrate plasma. It is the product of an intragenic triplication and is composed of three homologous domains. Oligonucleotide probes constructed according to published amino acid sequences were used to identify cDNA clones encoding human CP. Two clones, CP-1 and CP-2, differed from each other by the presence or absence, respectively, of a deduced sequence of four amino acids. The two clones provided 81% of the sequence encoding CP. Comparison of the nucleotides of the three domains of the CP coding sequence revealed internal domain homology with identity of sequences ranging from 50.1% to 56%. The nucleotide sequence of CP-2 cDNa was compared to that of a homologous human protein, clotting factor VIII, and was found to be 48% identical overall. The CP gene was mapped to human chromosome 3 by somatic-cell-hybrid analysis and to 3q25 by in situ hybridization; however, sites of hybridization to DNA on other chromosomal sites suggested additional CP-like DNA sequences in the human genome. A DNA polymorphism was detected with CP cDNA after endonuclease digestion of human DNA by Pst I. CP mRNA was detected in human liver, macrophages, and lymphocytes by in situ histohybridization.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486416      PMCID: PMC323492          DOI: 10.1073/pnas.83.10.3257

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Ceruloplasmin. A scavenger of superoxide anion radicals.

Authors:  I M Goldstein; H B Kaplan; H S Edelson; G Weissmann
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

2.  Demonstration of inherited ceruloplasmin variants in human Serum by acrylamide electrophoresis.

Authors:  M L McCombs; B H Bowman
Journal:  Tex Rep Biol Med       Date:  1969

3.  Two new ceruloplasmin variants in Negroes--data on three populations.

Authors:  M H Shokeir; D C Shreffler
Journal:  Biochem Genet       Date:  1970-08       Impact factor: 1.890

4.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

5.  Nucleotide sequence of cloned rat serum albumin messenger RNA.

Authors:  T D Sargent; M Yang; J Bonner
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

6.  Localization of single copy DNA sequences of G-banded human chromosomes by in situ hybridization.

Authors:  M E Harper; G F Saunders
Journal:  Chromosoma       Date:  1981       Impact factor: 4.316

7.  Evidence for linkage between the transferrin locus (Tf) and the serum cholinesterase locus (E1) in man.

Authors:  E B Robson; I Sutherland; H Harris
Journal:  Ann Hum Genet       Date:  1966-05       Impact factor: 1.670

8.  Ceruloplasmin: the copper transport protein with essential oxidase activity.

Authors:  E Frieden; H S Hsieh
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1976

9.  Direct assignment of orosomucoid to human chromosome 9 and alpha 2HS-glycoprotein to chromosome 3 using human fetal liver x rat hepatoma hybrids.

Authors:  D W Cox; U Francke
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  29 in total

Review 1.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M R Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  Caeruloplasmin biosynthesis by the human uterus.

Authors:  M L Schilsky; R J Stockert; J W Pollard
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

Review 3.  Mouse chromosome 9.

Authors:  D M Kingsley
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

Review 4.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

5.  Restriction fragment length polymorphism studies show consistent loss of chromosome 3p alleles in small cell lung cancer patients' tumors.

Authors:  B E Johnson; A Y Sakaguchi; A F Gazdar; J D Minna; D Burch; A Marshall; S L Naylor
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

6.  Protective role of macrophage-derived ceruloplasmin in inflammatory bowel disease.

Authors:  Bakytzhan Bakhautdin; Maria Febbraio; Esen Goksoy; Carol A de la Motte; Muhammet F Gulen; Erin Patricia Childers; Stanley L Hazen; Xiaoxia Li; Paul L Fox
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

7.  Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.

Authors:  Z L Harris; Y Takahashi; H Miyajima; M Serizawa; R T MacGillivray; J D Gitlin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.

Authors:  G F Chowrimootoo; H A Ahmed; C A Seymour
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

9.  Human alpha 2-HS-glycoprotein: the A and B chains with a connecting sequence are encoded by a single mRNA transcript.

Authors:  C C Lee; B H Bowman; F M Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

Review 10.  A general map of iron metabolism and tissue-specific subnetworks.

Authors:  Valerie Hower; Pedro Mendes; Frank M Torti; Reinhard Laubenbacher; Steven Akman; Vladmir Shulaev; Suzy V Torti
Journal:  Mol Biosyst       Date:  2009-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.